Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467590) titled 'Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study' on March 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Condition:
Refractory Colorectal Cancer
Radiotherapy-Induced Immune Priming
Immune Response
Intervention:
Radiation: High- and Low-Dose Radiotherapy
Recruitment Status: Not recruiting
Phase: Phase 2
Date of...